IMMX

Morris Gabriel S

Known title: Chief Financial OfficerCIK: 0001889967

Morris Gabriel S's purchase track record

How the stock did after each of Morris Gabriel S's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
7
of 7 since December 20, 2021
Stock higher 6 months later
71%
3 months: 57%
Median 6-month return
+23.8%
3 months: +12.7%
Beat the S&P 500
71%
median +16.0% vs. index
PurchaseStockAmount3 months6 months
12/10/2025IMMX$5K+55.4%+21.6%
9/16/2025IMMX$5K+197.0%+456.0%
6/18/2025IMMX$5K-18.0%+132.6%
6/4/2024IMMX$11K+12.7%+23.8%
5/14/2024IMMX$10K-15.4%-21.8%
11/14/2022IMMX$5K+131.1%+100.0%
12/20/2021IMMX$10K-31.7%-29.8%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

IMMX Holds Shareholder and Analyst Call. Immix Biopharma hosted a shareholder and analyst conference call, sharing recent company updates and answering questions. The discussion gave participants insight into the company's current activities and outlook. Such calls can influence how investors view the business and its progress.

this person other insiders at IMMX

Transaction History

IMMX▲ Buy$5K
IMMX▼ Sell$125K
IMMX▲ Buy$5K
IMMX▲ Buy$5K
IMMX▲ Buy$5K
IMMX▲ Buy$6K
IMMX▲ Buy—
IMMX▲ Buy—
IMMX▲ Buy—
IMMX▲ Buy$10K
IMMX▲ Buy$5K
IMMX▼ Sell$63K
IMMX▼ Sell$105K
IMMX▼ Sell$105K
IMMX▲ Buy$10K

We use analytics to understand how market-wall is used. No personal data is sold.